Invention Publication
- Patent Title: FACTOR XIa INHIBITORS
- Patent Title (中): 因子XIa抑制剂
-
Application No.: EP14776100.1Application Date: 2014-03-21
-
Publication No.: EP2978425A2Publication Date: 2016-02-03
- Inventor: OGAWA, Anthony , EDMONDSON, Scott , ERION, Mark , NEELAMKAVIL, Santosh , GUO, Zhuyan , MAL, Rudrajit , HE, Jiafang , LIU, Weiguo , VANDE BUNTE, Ellen, K.
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: 126 East Lincoln Avenue Rahway, NJ 07065 US
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: 126 East Lincoln Avenue Rahway, NJ 07065 US
- Agency: Hussain, Deeba
- Priority: US201361805733P 20130327
- International Announcement: WO2014160592 20141002
- Main IPC: A61K31/435
- IPC: A61K31/435
Abstract:
The present invention provides a compound of Formula (I) and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes.
Public/Granted literature
- EP2978425B1 FACTOR XIA INHIBITORS Public/Granted day:2017-09-27
Information query
